首页> 外文期刊>Russian journal of genetics >Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations
【24h】

Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations

机译:预测患有PAH基因突变的PKU / MHP患者的临床/生化表型

获取原文
获取原文并翻译 | 示例
           

摘要

Phenylketonuria (PKU) and mild hyperphenylalaninemia (MHP) are allelic disorders caused by mutations in the gene encoding phenylalanine hydroxylase (PAH). In this study, a total of 218 independent PAH chromosomes (109 unrelated patients with PKU residing in Lithuania) were investigated. All 13 exons of the PAH gene of all PKU probands were scanned for DNA alterations by denaturing gradient gel electrophoresis (DGGE). In the cases of a specific DGGE pattern recognized, mutations were identified by direct fluorescent automated sequencing or by restriction enzyme digestion analysis of relevant exons. Twenty-five different PAH gene mutations were identified in Lithuania. We estimated a connection between individual PAH locus mutations and biochemical and metabolic phenotypes in patients in whom the mutant allele acts on its own, i.e., in functionally hemizygous patients and using the assigned value (AV) method to determine the severity of both common and rare mutant alleles, as well as to check a model to predict the combined phenotypic effect of two mutant PAH alleles.
机译:苯丙酮尿症(PKU)和轻度高苯丙氨酸血症(MHP)是由编码苯丙氨酸羟化酶(PAH)的基因突变引起的等位基因疾病。在这项研究中,共调查了218条独立的PAH染色体(109名与立陶宛无关的PKU患者)。通过变性梯度凝胶电泳(DGGE)扫描所有PKU先证者的PAH基因的所有13个外显子的DNA改变。如果识别出特定的DGGE模式,则可通过直接荧光自动测序或相关外显子的限制性酶切分析来鉴定突变。在立陶宛确定了25种不同的PAH基因突变。我们估计了突变等位基因独自发挥作用的患者(即功能性半合子患者)中单个PAH基因座突变与生化和代谢表型之间的联系,并使用赋值(AV)方法确定常见和罕见病的严重性突变等位基因,以及检查模型以预测两个突变PAH等位基因的综合表型效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号